Circa Group AS (OSL:CIRCA) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Circa Group AS Debt-to-Equity?

Circa Group AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Circa Group AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Circa Group AS's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr329.16 Mil. Circa Group AS's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Circa Group AS's Debt-to-Equity or its related term are showing as below:

During the past 4 years, the highest Debt-to-Equity Ratio of Circa Group AS was -1.61. The lowest was -1.61. And the median was -1.61.

OSL:CIRCA's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.145
* Ranked among companies with meaningful Debt-to-Equity only.

Circa Group AS Debt-to-Equity Historical Data

The historical data trend for Circa Group AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circa Group AS Debt-to-Equity Chart

Circa Group AS Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-1.61

Circa Group AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Circa Group AS's Debt-to-Equity

For the Biotechnology subindustry, Circa Group AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Circa Group AS's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circa Group AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Circa Group AS's Debt-to-Equity falls into.

Circa Group AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Circa Group AS's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.138)	/	345.829
	=	0.00

Circa Group AS's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	329.16
	=	0.00

Circa Group AS (OSL:CIRCA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Circa Group AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Circa Group AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Circa Group AS (OSL:CIRCA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

8U5:Germany

Address

Karenslyst alle 53, Oslo, NOR, 0279

Website

https://www.circa-group.com

Circa Group AS is a biotechnology company. The company is engaged in converting waste biomass into advanced biochemical materials. Its Furacell production process takes abundant waste biomass and makes a platform molecule, levoglucosenone.

Circa Group AS (OSL:CIRCA) Headlines

No Headlines